Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in theLRRK2gene-Reference-Cited by-同舟云学术

Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in theLRRK2gene

Published:2015-03-21 Issue:7 Volume:30 Page:981-986
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Mirelman Anat¹,Alcalay Roy N.²³,Saunders-Pullman Rachel⁴⁵,Yasinovsky Kira¹,Thaler Avner¹,Gurevich Tanya¹⁶,Mejia-Santana Helen²,Raymond Deborah⁴,Gana-Weisz Mali⁷,Bar-Shira Anat⁷,Ozelius Laurie⁸,Clark Lorraine⁹¹⁰,Orr-Urtreger Avi⁶⁷,Bressman Susan⁴⁵,Marder Karen²³,Giladi Nir¹⁶¹¹,

Affiliation:

1. Movement Disorders Unit; Department of Neurology; Tel-Aviv Medical Center; Department of Neurology; Israel

2. College of Physicians and Surgeons; Columbia University; New York NY USA

3. Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University; New York NY USA

4. The Alan and Barbara Mirken Department of Neurology; Mount Sinai-Beth Israel Medical Center; New York New York USA

5. Icahn School of Medicine at Mount Sinai; New York NY USA

6. Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv Israel

7. Genetics Institute, Tel Aviv Sourasky Medical Center; Israel

8. Departments of Genetics and Genomic Sciences and Neurology; Mount Sinai School of Medicine; New York NY USA

9. Department of Pathology and Cell Biology; College of Physicians and Surgeons, Columbia University; New York NY USA

10. Center for Human Genetics, College of Physicians and Surgeons, Columbia University; New York NY USA

11. Sieratzki Chair in Neurology; Tel-Aviv University; New York NY USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference30 articles.

1. The natural history of treated Parkinson's disease in an incident, community based cohort;Evans;J Neurol Neurosurg Psychiatry,2011

2. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?;Orr-Urtreger;Neurology,2007

3. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews;Ozelius;N Engl J Med,2006

4. Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease;Goldwurm;Neurology,2007

5. 2013

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Genetic Landscape of Sleep Disorders in Parkinson’s Disease;Diagnostics;2024-01-03

2. Current genetic data on depression and anxiety in Parkinson's disease patients;Parkinsonism & Related Disorders;2024-01

3. Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson’s disease;npj Parkinson's Disease;2023-09-12

4. Imaging Markers in Genetic Forms of Parkinson’s Disease;Brain Sciences;2023-08-16

5. Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach;Current Neurology and Neuroscience Reports;2023-03-07